This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies
Herzlinger, Regina E.; Otazo, AndrewCase HBS-315045-EEntrepreneurshipA medical device startup seeks to complete its clinical trials with very little startup funding and a small staff when compared to its competitors.Starting at €8.20
-
Caso de estudio: Un inversionista ngel con una agenda personal
Herzlinger, Regina E.; Munoz-Seca, BeatrizArticle HBS-R1103MEntrepreneurshipGloria Londoño, el dueño de una cadena de centros de día innovadoras e integrales para las personas mayores en España, se ofrece 3 millones de euros por Victor Serna, un acaudalado médico-inversor. A cambio, Serna quiere una participación del 25%, un puesto en la junta, un voto en todas las decisiones estratégicas, y la posibilidad de liquidar su posición en cinco años, ya sea a través de una oferta pública o una venta. Sus términos no son negoci...Starting at €8.20
-
An Angel Investor with an Agenda (HBR Case Study)
Herzlinger, Regina E.; Munoz-Seca, BeatrizArticle HBS-R1103X-EEntrepreneurshipGloria Londono, the owner of a chain of innovative, holistic day care centers for the elderly in Spain, is offered 3 million euro by Victor Serna, a wealthy physician-investor. In exchange, Serna wants a 25% stake, a board seat, a vote on all strategic decisions, and the ability to liquidate his position in five years, either through a public offering or a sale. His terms are not negotiable; his objectives are not transparent. The money would ena...Starting at €8.20
-
The Global Sight Initiative
Herzlinger, Regina E.Case HBS-311034-EEntrepreneurshipHow to replicate a 'one of' social entrepreneurship effort: To cure blindness, Seva took the Aravind Eye Hospital & scaled it up to 100 hospitals globally.Starting at €8.20
-
ClearLife: From Prospect to Platform
Braun, Alexander; Cohen, Lauren H.; Elvedi, Mauro; Xu, JiahuaCase HBS-219119-EEntrepreneurshipClearLife's first product was a trading and analytics platform for participants in the US life settlement market, the secondary market for life insurance. ClearLife played a key role in facilitating transactions and devising a common language for expressing value and risk in this alternative asset class, and soon became the leading service provider in this market. After six years, ClearLife began to search for new business opportunities and ident...Starting at €8.20
-
ClearLife: From Prospect to Platform, Teaching Note
Braun, Alexander; Cohen, Lauren H.; Elvedi, Mauro; Xu, JiahuaTeaching Note HBS-220036-EEntrepreneurshipTeaching note for case 219119.Starting at €0.00
-
fidentiaX: The Tradable Insurance Marketplace on Blockchain, Teaching Note
Braun, Alexander; Cohen, Lauren H.; Xu, JiahuaTeaching Note HBS-220037-EEntrepreneurshipTeaching note for case 219116.Starting at €0.00
-
An Angel Investor with an Agenda (HBR Case Study and Commentary)
Herzlinger, Regina E.; Munoz-Seca, BeatrizArticle HBS-R1103M-EEntrepreneurshipGloria Londono, the owner of a chain of innovative, holistic day care centers for the elderly in Spain, is offered 3 million euro by Victor Serna, a wealthy physician-investor. In exchange, Serna wants a 25% stake, a board seat, a vote on all strategic decisions, and the ability to liquidate his position in five years, either through a public offering or a sale. His terms are not negotiable; his objectives are not transparent. The money would ena...Starting at €8.20
-
An Angel Investor with an Agenda (Commentary for HBR Case Study)
Herzlinger, Regina E.; Munoz-Seca, BeatrizArticle HBS-R1103Z-EEntrepreneurshipGloria Londono, the owner of a chain of innovative, holistic day care centers for the elderly in Spain, is offered 3 million euro by Victor Serna, a wealthy physician-investor. In exchange, Serna wants a 25% stake, a board seat, a vote on all strategic decisions, and the ability to liquidate his position in five years, either through a public offering or a sale. His terms are not negotiable; his objectives are not transparent. The money would ena...Starting at €8.20
-
CV Ingenuity (B)
Herzlinger, Regina E.; Otazo, AndrewCase HBS-315087-EEntrepreneurshipA medical device startup seeks to complete its clinical trials with very little startup funding and a small staff when compared to its competitors.Starting at €5.74